Skip to main content

Membranous Nephropathy clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

    Sorry, not currently recruiting here

    This study is a Phase 1b/2a, open-label, sequential-cohort, dose escalation, and dose expansion study to evaluate the safety, tolerability, PK, and PD of VB119 in subjects with primary MN

    San Francisco, California and other locations

Last updated: